Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP system

International Journal of Hematology

Volumn 86, Issue 3, 2007, Pages 269-274

  Atsuta, Yoshiko ^a   Suzuki, Ritsuro ^a   Yoshimi, Ayami ^a   Gondo, Hisashi ^b   Tanaka, Junji ^b   Hiraoka, Akira ^b   Kato, Koji ^c   Tabuchi, Ken ^c   Tsuchida, Masahiro ^c   Morishima, Yasuo ^d   Mitamura, Makoto ^d   Kawa, Keisei ^d   Kato, Shunichi ^e   Nagamura, Tokiko ^c   Takanashi, Minoko ^c   Kodera, Yoshihisa ^b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Japan Society for Hematopoietic Cell Transplantation   (Japan)

^c Japanese Society of Pediatric Hematology   (Japan)

^d Sample Management Committee   (Japan)

^e Tokyo Cord Blood Bank   (Japan)

Author keywords

Hematopoietic stem cell transplantation; Registry; Unification

Indexed keywords

ACCURACY; ARTICLE; ASIA; AWARENESS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; JAPAN; ORGANIZATION; PATIENT INFORMATION; QUALITY CONTROL; REGISTER;

DATABASES, FACTUAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; JAPAN; NATIONAL HEALTH PROGRAMS; REGISTRIES; SOCIETIES, MEDICAL;

EID: 36048965931     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.06239     Document Type: Article

References (37)

1. The Japan Society for Hematopoietic Cell Transplantation. Annual Report of Nationwide Survey 2005. (in Japanese) Nagoya, The Japan Society for Hematopoietic Cell Transplantation; 2006.
2. Report of unrelated bone marrow transplantation through the Japan Marrow Donor Program: 2005 summary, (in Japanese). Tokyo, The Japan Marrow Donor Program; 2006.
3. Imamura M, Asano S, Harada M, et al, Current status of hematopoietic cell transplantation for adult patients with hematologic diseases and solid tumors in Japan. Int J Hematol. 2006;83:164-178.
4. Malsuo K, Hamajima N, Morishima Y, Harada M. Hospital capacity and post-transplant survival after allogeneic bone marrow transplantation: analysis of data from the Japan Society for Hematopoietic Cell Transplantation. Bone Marrow Transplant. 2000;26:1061-1067.
5. Tamaki S, Ichinohe T, Matsuo K, Hamajima N, Hirabayashi N, Dohy H. Superior survival of blood and marrow stem cell recipients given maternal grafts over recipients given paternal grafts. Bone Marrow Transplant. 2001;28:375-380.
6. Kanda Y, Chiba S, Hirai H, et al. Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991-2000). Blood. 2003;102:1541-1547.
7. Kataoka I, Kami M, Takahashi S, et al. Clinical impact of graft-versus-host disease against leukemias not in remission at the lime of allogeneic hematopoietic stem cell transplantation from related donors. The Japan Society for Hematopoietic Cell Transplantation Working Party. Bone Marrow Transplant. 2004;34:711-719.
8. Ogawa H, Ikegame K, Kawakami M, et al. Impact of cytogenetics on outcome of stem cell transplantation for acute myeloid leukemia in first remission: a large-scale retrospective analysis of data from the Japan Society for Hematopoietic Cell Transplantation. Int J Hematol. 2004;79:495-500.
9. Yanada M, Emi N, Naoe T, et al. Allogeneic myeloablative transplantation for patients aged 50 years and over. Bone Marrow Transplant. 2004;34:29-35.
10. Nakai K, Kanda Y, Fukuhara S, et al. Value of chemotherapy before allogeneic hematopoietic stem cell transplantation from an HLA-identical sibling donor for myelodysplastic syndrome. Leukemia. 2005;19:396-401.
11. Bone Marrow Transplantation Committee. National registry of bone marrow transplantation in children (1984). J Jpn Pediatr Soc. 1985;89:159-63.
12. Bone Marrow Transplantation Committee. National registry of bone marrow transplantation in children (1994). Jpn J Pediatr Hematol. 1994;8:492-504.
13. Okamura J, Matsuyama T, Yazaki M, et al. National registry of stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in children: results of analyses of 89 cases. Jpn J Pediatr Hematol. 1999;13:170-177.
14. Kigasawa H, Kato S, Akiyama Y et al. National registry of Hematopoietic Stem-cell Transplantation in children (1998). Jpn J Pediatr Hematol. 2000;14:317-327.
15. Imaizumi M, Yabe H, Matsuyama K, et al. The current state and challenges of hematopoietic cell transplantation for congenital metabolic diseases (in Japanese). J Jpn Pediatr Soc. 2003;107:53-60.
16. Sasazuki T, Juji T, Morishima Y, et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program. N Engl J Med. 1998;339:1177-1185.
17. Kodera Y, Morishima Y, Kato S, et al. Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia. Bone Marrow Transplant. 1999;24:995-1003.
18. Nishimori M, Yamada Y, Hoshi K, et al. Health-related quality of life of unrelated bone marrow donors in Japan. Blood. 2002;99:1995-2001.
19. Kojima S, Matsuyama T, Kato S, et al. Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program. Blood. 2002;100:799-803.
20. Izutsu K, Kanda Y, Ohno H, et al. Unrelated bone marrow transplantation for non-Hodgkin lymphoma: a study from the Japan Marrow Donor Program. Blood. 2004;103:1955-1960.
21. Nishihira H, Kato K, Isoyama K, et al. The Japanese cord blood bank network experience with cord blood transplantation from unrelated donors for haematological malignancies: an evaluation of graft-versus-host disease prophylaxis. Br J Haematol. 2003;120:516-522.
22. Isoyama K, Ohnuma K, Kato K, et al. Cord blood transplantation from unrelated donors: a preliminary report from the Japanese Cord Blood Bank Network. Leuk Lymphoma. 2003;44:429-438.
23. Bortin MM, Rimm AA for the Advisory Committee to the Registry. ACS-NIH organ transplant registry. Second scientific report. JAMA. 1972;221:1486-1491.
24. Speck B, Bortin MM, Champlin R, et al. Allogeneic bone-marrow transplantation for chronic myelogenous leukaemia. Lancet. 1984;1:665-668.
25. Bortin MM, Horowitz MM, Gale RR et al. Changing trends in allogeneic bone marrow transplantation for leukemia in the 1980s. JAMA. 1992;268:607-612.
26. Ringden O, Horowitz MM, Gale RR et al. Outcome after allogeneic bone marrow transplant for leukemia in older adults. JAMA. 1993;270:57-60.
27. Silberman G, Crosse MG, Peterson EA, et al. Availability and appropriateness of allogeneic bone marrow transplantation for chronic myeloid leukemia in 10 countries. N Engl J Med. 1994;331:1063-1067.
28. Szydlo R, Goldman JM, Klein JP, et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J. Clin Oncol. 1997;15:1767-1777.
29. Socie G, Stone JV, Wingard JR, et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med. 1999;341:14-21.
30. Lee SJ, Klein JR Barrett AJ, et al. Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood. 2002;100:406-414.
31. Gratwohl A. Bone marrow transplantation activity in Europe 1990. European Group for Bone Marrow Transplantation (EBMT). Bone Marrow Transplant. 1991;8:197-201.
32. Gratwohl A, Passweg J, Baldomero H, Hermans J. Blood and marrow transplantation activity in Europe 1997. European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 1999;24:231-245.
33. Gratwohl A, Baldomero H, Frauendorfer K, Urbano-Ispizua A. EBMT activity survey 2004 and changes in disease indication over the past 15 years. Bone Marrow Transplant. 2006;37:1069-1085.
34. Bacigalupo A, Hows J, Gluckman E, et al. Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party. Br J Haematol. 1988;70:177-182.
35. Cahn JY, Labopin M, Schattenberg A, et al. Allogeneic bone marrow transplantation for acute leukemia in patients over the age of 40 years. Acute Leukemia Working Party of the European Group for Bone Marrow Transplantation (EBMT). Leukemia. 1997;11:416-419.
36. Gratwohl A, Hermans J, Goldman JM, et al. Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet. 1998;352:1087-1092.
37. Rocha V, Labopin M, Gluckman E, et al. Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European survey. J Clin Oncol. 2002;20:4324-4330.